Real-time enrollment status for this hepatic impairment (hi) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:54 PM UTC
| NCT Number | NCT07324616 |
| Recruiting Status | Recruiting |
| Condition | Hepatic Impairment (HI) |
| Phase | Clinical Trial |
| Target Enrollment | 32 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Edgewise Therapeutics, Inc. |
| Last Updated on CT.gov | March 9, 2026 (Mar 9, 2026) |
As of July 13, 2026: Clinical trial NCT07324616 is currently recruiting participants. This clinical trial study for hepatic impairment (hi) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Edgewise Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07324616 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07324616 was last updated Mar 9, 2026 (March 9, 2026). HelloStudys verifies this status automatically.